Zigmars Sebris

Q: What is Zigmars Sebris email address?

Email Zigmars Sebris at sebris@gmail.com and zigmars.sebris@ema.europa.eu. This email is the most updated Zigmars Sebris's email found in 2026.

Q: How to contact Zigmars Sebris?

To contact Zigmars Sebris send an email to sebris@gmail.com or zigmars.sebris@ema.europa.eu. (updated on June 21, 2025)

Strategic Support and Crisis Response Specialist at European Medicines Agency | Netherlands

About Zigmars Sebris

Zigmars Sebris currently serves as a Scientific Administrator and EMA Product Lead at the European Medicines Agency, where he plays a pivotal role in shaping the agency’s strategic approach to medicinal product regulation and pharmacovigilance. In his capacity as a Product Team Leader, Zigmars oversees critical projects related to the assessment and monitoring of innovative therapies, including vaccines, biologics, and medical devices. His expertise in regulatory affairs and quality assurance ensures that the agency maintains high standards for clinical development, compliance, and safety across a broad spectrum of medicinal products.

A key aspect of Zigmars’s role involves providing scientific and regulatory support for complex crisis situations, such as public health emergencies or safety alerts. His strategic support and crisis coordination skills enable the EMA to respond swiftly and effectively, safeguarding public health while maintaining regulatory integrity. He is deeply involved in cross-Agency activities that promote harmonized approaches to pharmacovigilance and risk management, fostering collaboration among stakeholders and international partners.

With a strong background in clinical trials, GCP, and life sciences, Zigmars contributes to the development and implementation of policies that enhance the safety and efficacy of medicines. His work also encompasses health economics and the evaluation of clinical research data, ensuring that regulatory decisions are evidence-based and aligned with industry standards. Through his leadership, Zigmars continues to strengthen the EMA’s capacity to oversee the lifecycle of medicinal products, supporting innovation while upholding rigorous safety and quality benchmarks.

Zigmars Sebris Work